| Literature DB >> 20817181 |
Mi Jin Kim1, Dae Won Kim, Ki-Yeon Yoo, Eun Jeong Sohn, Hoon Jae Jeong, Hye Won Kang, Min Jea Shin, Eun Hee Ahn, Jae Jin An, Soon Won Kwon, Young Nam Kim, Moo Ho Won, Sung-Woo Cho, Jinseu Park, Won Sik Eum, Soo Young Choi.
Abstract
Reactive oxygen species (ROS) actively contribute to the development of a number of human diseases including ischemia. In response to oxidative stress, frataxin has a significant ability to improve cell survival though its biological function is unclear in relation to ischemia. To explore frataxin's role in protecting against ischemic cell death, we constructed PEP-1-Frataxin cell-permeable fusion protein. In a dose- and time-dependent manner PEP-1-Frataxin rapidly transduced into astrocyte cells and protected them against oxidative stress-induced cell death. Further, using an animal model, immunohistochemical analysis revealed that PEP-1-Frataxin prevented neuronal cell death in the CA1 region of the hippocampus induced by transient forebrain ischemia. These results demonstrate that transduced PEP-1-Frataxin protects against cell death in vitro and in vivo, suggesting that transduction of PEP-1-Frataxin could be useful as a therapeutic agent for various human diseases related to oxidative stress.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20817181 DOI: 10.1016/j.jns.2010.08.016
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181